TrialThe New England journal of medicine2021
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.
REMAP-CAP Investigators et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1,103 papers cite itlatest 60 shown
this paperpooled ittrialcites it